Evidence map›Paper›PMID 35360260›Full record

ArticleLaser & photonics reviews2021

Photonic technologies for liquid biopsies: recent advances and open research challenges.

Francesco Dell'Olio, Judith Su, Thomas Huser, Virginie Sottile, Luis Enrique Cortés-Hernández, Catherine Alix-Panabières

Open access · greenAbstract read
In one paragraph

Article in Laser & photonics reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Breaking the mold: 3D cell cultures reshaping the future of cancer research.Frontiers in cell and developmental biology · 2024
    Review
  12. Article
  13. Article
  14. Advances in the application of Raman spectroscopy in haematological tumours.Frontiers in bioengineering and biotechnology · 2022
    Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 5 countries.

Francesco Dell'OlioDepartment of Electrical and Information Engineering, Polytechnic University of Bari, 70125, Italy.
Judith SuDepartment of Biomedical Engineering, College of Optical Sciences, and BIO5 Institute, University of Arizona, 85721, USA.
Thomas HuserBiomolecular Photonics, Department of Physics, University of Bielefeld, 33615 Germany.
Virginie SottileDepartment of Molecular Medicine, University of Pavia, 27100, Italy.
Luis Enrique Cortés-HernándezLaboratory of Rare Human Circulating Cells (LCCRH), University Medical Center of Montpellier, 34093 CEDEX 5, France.
Catherine Alix-PanabièresLaboratory of Rare Human Circulating Cells (LCCRH), University Medical Center of Montpellier, 34093 CEDEX 5, France.
Université de Montpellier · FRBielefeld University · DEPolytechnic University of Bari · ITUniversity of Arizona · USUniversity of Nottingham · GB

Funding

Label-free, highly-specific, small molecule detection using microtoroid optical resonatorsR21MH111109 · NIMH · UNIVERSITY OF ARIZONA · PI SU, JUDITH · 2016 to 2017
$396k
Ultra-sensitive and label-free detection of Alzheimer's disease biomarkersR03AG055020 · NIA · UNIVERSITY OF ARIZONA · PI SU, JUDITH · 2017 to 2018
$164k
NIA NIH HHS R03 AG055020NIMH NIH HHS R21 MH111109
6 · The paper itself

Abstract

The recent development of sophisticated techniques capable of detecting extremely low concentrations of circulating tumor biomarkers in accessible body fluids, such as blood or urine, could contribute to a paradigm shift in cancer diagnosis and treatment. By applying such techniques, clinicians can carry out liquid biopsies, providing information on tumor presence, evolution, and response to therapy. The implementation of biosensing platforms for liquid biopsies is particularly complex because this application domain demands high selectivity/specificity and challenging limit-of-detection (LoD) values. The interest in photonics as an enabling technology for liquid biopsies is growing owing to the well-known advantages of photonic biosensors over competing technologies in terms of compactness, immunity to external disturbance, and ultra-high spatial resolution. Some encouraging experimental results in the field of photonic devices and systems for liquid biopsy have already been achieved by using fluorescent labels and label-free techniques and by exploiting super-resolution microscopy, surface plasmon resonance, surface-enhanced Raman scattering, and whispering gallery mode resonators. This paper critically reviews the current state-of-the-art, starting from the requirements imposed by the detection of the most common circulating biomarkers. Open research challenges are considered together with competing technologies, and the most promising paths of improvement are discussed for future applications.

Indexed as

liquid biopsiesoncologyoptical microscopyplasmonicswhispering gallery modes

Identifiers

PMID35360260
PMCPMC8966629
OpenAlexW3110550845

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.